On March 13, 2026, engineers at Duke University demonstrated a technique called SonoPIN, which uses microbubbles and ultrasound to enhance the intracellular delivery of large cancer drugs. In a benchtop experiment, this technology caused 50% of targeted cancer cells to self-destruct while preserving 99% of non-targeted cells. This follows news from March 12, 2026, when a new Duke study raised concerns regarding the potential risks of Roundup for gardeners.
Similar Companies
Subscribe for full access to Duke University's profile
Duke University offers products in the sports industry. Duke University's product portfolio comprises of athletics and multi-discipline sports.
Subscribe for full access to Duke University's products in full detail
Subscribe for full access to Duke University's revenue in full detail